1
|
Development and therapeutic potential of 2-aminothiazole derivatives in anticancer drug discovery. Med Chem Res 2021; 30:771-806. [PMID: 33469255 PMCID: PMC7809097 DOI: 10.1007/s00044-020-02686-2] [Citation(s) in RCA: 27] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2020] [Accepted: 12/06/2020] [Indexed: 11/01/2022]
Abstract
Currently, the development of anticancer drug resistance is significantly restricted the clinical efficacy of the most commonly prescribed anticancer drug. Malignant disease is widely prevalent and considered to be the major challenges of this century, which concerns the medical community all over the world. Consequently, investigating small molecule antitumor agents, which could decrease drug resistance and reduce unpleasant side effect is more desirable. 2-aminothiazole scaffold has emerged as a promising scaffold in medicinal chemistry and drug discovery research. This nucleus is a fundamental part of some clinically applied anticancer drugs such as dasatinib and alpelisib. Literature survey documented that different 2-aminothiazole analogs exhibited their potent and selective nanomolar inhibitory activity against a wide range of human cancerous cell lines such as breast, leukemia, lung, colon, CNS, melanoma, ovarian, renal, and prostate. In this paper, we have reviewed the progresses and structural modification of 2-aminothiazole to pursuit potent anticancers and also highlighted in vitro activities and in silico studies. The information will useful for future innovation. Representatives of 2-aminothiazole-containing compounds classification.
Collapse
|
2
|
Guo R, Zuo M, Tian Q, Hou C, Sun S, Guo W, Wu H, Chu W, Sun Z. Visible Light‐Induced Decarboxylative Alkylation of Heterocyclic Aromatics with Carboxylic Acids via Anthocyanin as a Photocatalyst. Chem Asian J 2020; 15:1976-1981. [DOI: 10.1002/asia.202000277] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2020] [Revised: 05/07/2020] [Indexed: 11/07/2022]
Affiliation(s)
- Rui Guo
- School of Chemistry and Materials Science Key Laboratory of Chemical Engineering Process & Technology for High-efficiency ConversionHeilongjiang University Harbin 150080 P. R. China
| | - Minghui Zuo
- School of Chemistry and Materials Science Key Laboratory of Chemical Engineering Process & Technology for High-efficiency ConversionHeilongjiang University Harbin 150080 P. R. China
| | - Qinye Tian
- School of Chemistry and Materials Science Key Laboratory of Chemical Engineering Process & Technology for High-efficiency ConversionHeilongjiang University Harbin 150080 P. R. China
| | - Chuanfu Hou
- School of Chemistry and Materials Science Key Laboratory of Chemical Engineering Process & Technology for High-efficiency ConversionHeilongjiang University Harbin 150080 P. R. China
| | - Shouneng Sun
- School of Chemistry and Materials Science Key Laboratory of Chemical Engineering Process & Technology for High-efficiency ConversionHeilongjiang University Harbin 150080 P. R. China
| | - Weihao Guo
- School of Chemistry and Materials Science Key Laboratory of Chemical Engineering Process & Technology for High-efficiency ConversionHeilongjiang University Harbin 150080 P. R. China
| | - Hongfeng Wu
- School of Chemistry and Materials Science Key Laboratory of Chemical Engineering Process & Technology for High-efficiency ConversionHeilongjiang University Harbin 150080 P. R. China
| | - Wenyi Chu
- School of Chemistry and Materials Science Key Laboratory of Chemical Engineering Process & Technology for High-efficiency ConversionHeilongjiang University Harbin 150080 P. R. China
| | - Zhizhong Sun
- School of Chemistry and Materials Science Key Laboratory of Chemical Engineering Process & Technology for High-efficiency ConversionHeilongjiang University Harbin 150080 P. R. China
| |
Collapse
|
3
|
Hegde M, Vartak SV, Kavitha CV, Ananda H, Prasanna DS, Gopalakrishnan V, Choudhary B, Rangappa KS, Raghavan SC. A Benzothiazole Derivative (5g) Induces DNA Damage And Potent G2/M Arrest In Cancer Cells. Sci Rep 2017; 7:2533. [PMID: 28566733 PMCID: PMC5451441 DOI: 10.1038/s41598-017-02489-3] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2016] [Accepted: 04/12/2017] [Indexed: 11/25/2022] Open
Abstract
Chemically synthesized small molecules play important role in anticancer therapy. Several chemical compounds have been reported to damage the DNA, either directly or indirectly slowing down the cancer cell progression by causing a cell cycle arrest. Direct or indirect reactive oxygen species formation causes DNA damage leading to cell cycle arrest and subsequent cell death. Therefore, identification of chemically synthesized compounds with anticancer potential is important. Here we investigate the effect of benzothiazole derivative (5g) for its ability to inhibit cell proliferation in different cancer models. Interestingly, 5g interfered with cell proliferation in both, cell lines and tumor cells leading to significant G2/M arrest. 5g treatment resulted in elevated levels of ROS and subsequently, DNA double-strand breaks (DSBs) explaining observed G2/M arrest. Consistently, we observed deregulation of many cell cycle associated proteins such as CDK1, BCL2 and their phosphorylated form, CyclinB1, CDC25c etc. Besides, 5g treatment led to decreased levels of mitochondrial membrane potential and activation of apoptosis. Interestingly, 5g administration inhibited tumor growth in mice without significant side effects. Thus, our study identifies 5g as a potent biochemical inhibitor to induce G2/M phase arrest of the cell cycle, and demonstrates its anticancer properties both ex vivo and in vivo.
Collapse
Affiliation(s)
- Mahesh Hegde
- Department of Biochemistry, Indian Institute of Science, Bangalore, 560012, India.,Department of Studies in Chemistry, University of Mysore, Mysuru, 570006, India
| | - Supriya V Vartak
- Department of Biochemistry, Indian Institute of Science, Bangalore, 560012, India
| | | | - Hanumappa Ananda
- Department of Biochemistry, Indian Institute of Science, Bangalore, 560012, India
| | - Doddakunche S Prasanna
- Department of Nanotechnology, Visvesvaraya Technological University, Center for Postgraduate Studies, Bengaluru Region, Muddenahalli, Chikkaballapur, Bangalore, 562101, India
| | - Vidya Gopalakrishnan
- Department of Biochemistry, Indian Institute of Science, Bangalore, 560012, India.,Institute of Bioinformatics and Applied Biotechnology, Electronics City, Bangalore, 560100, India
| | - Bibha Choudhary
- Institute of Bioinformatics and Applied Biotechnology, Electronics City, Bangalore, 560100, India
| | | | - Sathees C Raghavan
- Department of Biochemistry, Indian Institute of Science, Bangalore, 560012, India.
| |
Collapse
|
4
|
Cao C, Wang W, Zhang F, Huang N, Zou K. TMSCl Promoted Direct sp3C-H Alkenylation to Construct (E)-2-Styryl-tetrahydrobenzo[d]thiazoles. CHINESE J CHEM 2015. [DOI: 10.1002/cjoc.201500341] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
5
|
Keri RS, Patil MR, Patil SA, Budagumpi S. A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry. Eur J Med Chem 2014; 89:207-51. [PMID: 25462241 DOI: 10.1016/j.ejmech.2014.10.059] [Citation(s) in RCA: 307] [Impact Index Per Article: 30.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2014] [Revised: 10/19/2014] [Accepted: 10/20/2014] [Indexed: 02/08/2023]
Abstract
Benzothiazole (BTA) and its derivatives are the most important heterocyclic compounds, which are common and integral feature of a variety of natural products and pharmaceutical agents. BTA shows a variety of pharmacological properties, and its analogs offer a high degree of structural diversity that has proven useful for the search of new therapeutic agents. The broad spectrum of pharmacological activity in individual BTA derivative indicates that, this series of compounds is of an undoubted interest. The related research and developments in BTA-based medicinal chemistry have become a rapidly developing and increasingly active topic. Particularly, numerous BTA-based compounds as clinical drugs have been extensively used in practice to treat various types of diseases with high therapeutic potency. This work systematically gives a comprehensive review in current developments of BTA-based compounds in the whole range of medicinal chemistry as anticancer, antibacterial, antifungal, antiinflammatory, analgesic, anti-HIV, antioxidant, anticonvulsant, antitubercular, antidiabetic, antileishmanial, antihistaminic, antimalarial and other medicinal agents. It is believed that, this review article is helpful for new thoughts in the quest for rational designs of more active and less toxic BTA-based drugs, as well as more effective diagnostic agents and pathologic probes.
Collapse
Affiliation(s)
- Rangappa S Keri
- Centre for Nano and Material Sciences, Jain University, Jain Global Campus, Bangalore 562112, Karnataka, India.
| | - Mahadeo R Patil
- Centre for Nano and Material Sciences, Jain University, Jain Global Campus, Bangalore 562112, Karnataka, India
| | - Siddappa A Patil
- Centre for Nano and Material Sciences, Jain University, Jain Global Campus, Bangalore 562112, Karnataka, India
| | - Srinivasa Budagumpi
- Centre for Nano and Material Sciences, Jain University, Jain Global Campus, Bangalore 562112, Karnataka, India
| |
Collapse
|
6
|
Karki SS, Panjamurthy K, Kumar S, Nambiar M, Ramareddy SA, Chiruvella KK, Raghavan SC. Synthesis and biological evaluation of novel 2-aralkyl-5-substituted-6-(4′-fluorophenyl)-imidazo[2,1-b][1,3,4]thiadiazole derivatives as potent anticancer agents. Eur J Med Chem 2011; 46:2109-16. [DOI: 10.1016/j.ejmech.2011.02.064] [Citation(s) in RCA: 58] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2011] [Revised: 02/13/2011] [Accepted: 02/24/2011] [Indexed: 10/18/2022]
|
7
|
Synthesis and Identification of a new class of antileukemic agents containing 2-(arylcarboxamide)-(S)-6-amino-4,5,6,7-tetrahydrobenzo[d]thiazole. Eur J Med Chem 2010; 45:5331-6. [DOI: 10.1016/j.ejmech.2010.08.056] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2010] [Revised: 08/20/2010] [Accepted: 08/25/2010] [Indexed: 11/17/2022]
|